Prostate Cancer Update 2022Catalona, William J.Dahl, Douglas M.Liauw, Stanley L.Loeb, StacyNadler, Robert B.Szmulewitz, RussellAUANews
The objective of the French Urology Association Cancer Committee is to propose an update of the recommendations for the management of prostate cancer. Methods A systematic review of the literature from 2020 to 2022 was conducted by the CCAFU on the elements of therapeutic management of metastatic ...
5 people interested. Check out who is attending ✭ exhibiting ✭ speaking ✭ schedule & agenda ✭ reviews ✭ timing ✭ entry ticket fees. 2022 edition of Annual International Prostate Cancer Update Conference will be held at The Cliff Lodge,
markers were further filtered to select cell surface markers (SPC42>2). PCa: Prostate cancer; NC: Non-cancer; SPC: Surface prediction consensus42.P-values from a two-sided Mann–WhitneyUtest.dTumor markers with predicted cell surface localization from (c). Proteins are annotated with the freq...
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
Prostate Cancer Prostatic Dis. 2022; https://doi.org/10.1038/s41391-022-00549-y Visser WCH, de Jong H, Steyaert S, Melchers WJG, Mulders PFA, Schalken JA. Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer. Prostate Cancer Prostatic Dis. 2022;25:583–9. ...
Review the quality control efforts for prostate MR and explain the current and future applications of artificial intelligence on prostate imaging 3) Understand the potential roles and added value of PSMA PET and PET MR in the management of patients with prostate cancer 4) Identify the basics of ...
Prostate cancer (PCa) is highly prevalent among males worldwide. The investigation of exosomes in PCa has emerged as a dynamic and important research area. To visually depict the prominent research areas and evolutionary patterns of exosomes in PCa, we performed a comprehensive analysis via bibliomet...
ASCO Germline Mutation Testing in Prostate Cancer – UPDATE ASCO Metastatic Systemic Castration-Resistant Prostate Cancer – UPDATE ASCO Primary Tumor-Directed and Metastasis-Directed Local Therapy in Metastatic Prostate Cancer ASCO Genitourinary Cancers Survivorship ASCO Special Considerations for Elderly Patient...
Among the 30 patients, 13 were pathologically confirmed to have prostate cancer. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of visual analysis in [18F]DCFPyL PET/CT imaging for diagnosing PI-RADS 3/4 lesions were 61.5%, 88.2%, 80.0%, 75.0%...